William Rose
Presidente presso Greenhill School
Profilo
William Edward Rose is currently the Chairman at Greenhill School.
He previously worked as a Managing Director at HBK Investments LP, a Director at Impac Mortgage Holdings, Inc., and as the President of Montrose Capital, Inc. He also served as an Independent Director at Reata Pharmaceuticals, Inc. from 2016 to 2023.
Mr. Rose received his undergraduate degree from Duke University in 1989.
Posizioni attive di William Rose
| Società | Posizione | Inizio |
|---|---|---|
| Greenhill School | Presidente | - |
Precedenti posizioni note di William Rose
| Società | Posizione | Fine |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 26/09/2023 |
| Montrose Capital, Inc. | Presidente | - |
HBK Investments LP
 HBK Investments LP Investment ManagersFinance HBK Investments LP, do-business-as HBK Capital Management (HBK), is a SEC-registered investment advisor and hedge fund manager headquartered in Dallas, Texas. The firm was founded in 1991 and is a subsidiary of HBK Partners II LP. HBK provides discretionary investment management services and related administrative services to their funds, which are private investment funds offered only to sophisticated investors with substantial resources. | Direttore degli Investimenti | - |
| IMPAC MORTGAGE HOLDINGS, INC. | Direttore/Membro del Consiglio | - |
Formazione di William Rose
| Duke University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| IMPAC MORTGAGE HOLDINGS, INC. | Finance |
| Aziende private | 3 |
|---|---|
HBK Investments LP
HBK Investments LP Investment ManagersFinance HBK Investments LP, do-business-as HBK Capital Management (HBK), is a SEC-registered investment advisor and hedge fund manager headquartered in Dallas, Texas. The firm was founded in 1991 and is a subsidiary of HBK Partners II LP. HBK provides discretionary investment management services and related administrative services to their funds, which are private investment funds offered only to sophisticated investors with substantial resources. | Finance |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
| Montrose Capital, Inc. |
- Borsa valori
- Insiders
- William Rose
